|
2017
|
Invention
|
Prevention or treatment agent for hepatic fibrosis. CBP/β-catenin inhibitor shows a superior defi... |
|
2016
|
Invention
|
Anticancer combination of a cbp/catenin inhibitor and an immune checkpoint inhibitor. The present... |
|
|
Invention
|
Anticancer agent. The purpose of the present invention is to provide a cancer treatment drug havi... |
|
2014
|
Invention
|
Crystal (1) of pyrazino[2,1-c][1,2,4]triazine compound.
Provided is a crystal of hydrate of 4-((... |
|
|
Invention
|
Crystals (2) of pyrazino[2,1-c][1,2,4]triazine compound.
Provided are a crystal of a hydrate of ... |
|
|
Invention
|
(6s,9as)-n-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazine-1-yl)azetidine-1-yl]... |
|
|
Invention
|
Crystals (2) of pyrazino[2,1-c][1,2,4]triazine compound. Provided are: a hydrated crystal of a co... |
|
|
Invention
|
Crystal (1) of pyrazino[2,1-c][1,2,4]triazine compound. Provided is a hydrated crystal of 4-(((6S... |
|
|
Invention
|
(6s,9as)-n-benzyl-8-((6-(3-(4-ethylpiperazin-1-yl)azetidin-1-yl)pyridin-2-yl)methyl)-6-((2-fluoro... |
|
|
Invention
|
(6s,9as)-n-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]py... |
|
|
Invention
|
Method of producing pyrazino[2,1-c][1,2,4]triazine compound.
A method of producing 4-(((6S,9S)-1... |
|
|
Invention
|
Method of producing pyrazino[2,1-c][1,2,4]triazine compound. This method of producing 4-(((6S,9S)... |
|
2013
|
Invention
|
Prevention or treatment agent for hepatic fibrosis. In the present invention, a CBP/β-catenin inh... |
|
|
Invention
|
Prophylactic or therapeutic agent for fibromyalgia. A substance capable of binding to mSin3B, sai... |
|
|
Invention
|
Treatment of viral and infectious diseases using an inhibitor of cbp/catenin.
The present disclo... |
|
|
Invention
|
Treatment of pulmonary fibrosis using an inhibitor of cbp/catenin.
The present disclosure relate... |
|
|
Invention
|
Method for treating type i and type ii diabetes.
The present disclosure relates generally to alp... |
|
|
Invention
|
Methods for treating eye disorders.
The present disclosure relates generally to alpha-helix mime... |
|
|
Invention
|
Treatment of hyperproliferative and pre-cancerous skin diseases using an inhibitor of cbp/catenin... |
|
|
Invention
|
Treatment of scleroderma using an inhibitor of cbp/catenin.
The present disclosure relates gener... |
|
|
Invention
|
Method for treating type i and type ii diabetes. The present disclosure relates generally to alph... |
|
|
Invention
|
Treatment of viral and infectious diseases using an inhibitor of cbp/catenin. The present disclos... |
|
|
Invention
|
Treatment of scleroderma using an inhibitor of cbp/catenin. The present disclosure relates genera... |
|
|
Invention
|
Methods for treating eye disorders. The present disclosure relates generally to alpha-helix mimet... |
|
|
Invention
|
Treatment of pulmonary fibrosis using an inhibitor of cbp/catenin. The present disclosure relates... |
|
|
Invention
|
Alpha helix mimetics and methods relating thereto. Alpha-helix mimetic structures and compounds r... |
|
2012
|
Invention
|
Alpha helix mimetics and methods relating thereto.
Alpha-helix mimetic structures and compounds ... |
|
2009
|
Invention
|
Alpha helix mimetics and methods relating thereto.
Alpha-helix mimetic structures and... |
